Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by ConnectTheDot1on Sep 05, 2018 8:06pm
32 Views
Post# 28569126

RE:RE:RE:ISOL LOVES FRIDAYS! GOOD NEWS COMING

RE:RE:RE:ISOL LOVES FRIDAYS! GOOD NEWS COMINGOh my! It seemed smelling fishy...by hiring a consulting firm to assist the shareholders' IR!!! :-( Please don't let me turn in the dark side of ISOL!
CBDANDME wrote: Hey Trend, 

I received an email as well see below

thank you for your interest in Isodiol. My name is Scott Eckstein, I’m with KCSA Strategic Communications, a New York-based communications firm. I work with Mike to support the Company’s investor relations activities. 
 
Regarding the CTO, the Company has submitted amended filings of its annual financial statements to the BCSC for the fiscal year ended March 31, 2018. We have been in  continuous dialogue with the BCSC and have been working with them to move forward as quickly as possible.  Upon approval from the BCSC, we will be filing the amended FY financials first and from there we can post our Q1 results.


Bullboard Posts